Skip to main content
Farzana Pashankar, MD, Pediatric Hematology & Oncology, New Haven, CT

Farzana Dinesh Pashankar MD


Professor of Pediatrics, Yale University School of Medicine

Join to View Full Profile
  • LMP 2073333 Cedar StreetNew Haven, CT 06510

  • Phone+1 203-785-4640

  • Fax+1 203-737-2228

Dr. Pashankar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Iowa Health Care Medical Center
    University of Iowa Health Care Medical CenterFellowship, Pediatric Hematology/Oncology, 2003 - 2004
  • University of Iowa Health Care Medical Center
    University of Iowa Health Care Medical CenterResidency, Pediatrics, 2001 - 2003
  • B.J. Medical College - University of Pune
    B.J. Medical College - University of PuneClass of 1988

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2004 - 2026
  • IA State Medical License
    IA State Medical License 2000 - 2005
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Howard A. Pearson Pediatric Faculty Teaching Award Yale University School of Medicine, 2012, 2015
  • Pediatric Faculty Scholar Award Yale University School of Medicine, 2009
  • Travel Award, Sickle Cell Vasculopathy Conference NIH, 2008

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Is Adjuvant Chemotherapy indicated in Ovarian Immature Teratoma? A Combined Data Analysis from The Malignant Germ Cell Tumor International Collaborative (MaGIC)  
    Pashankar FD, Juliet P. Hale, Ha Dang, Mark Krailo, William E. Brady, Carlos Rodriguez-Galindo, James C. Nicholson, Matthew J. Murray, Deborah F. Bilmire, Sara Stoneha..., Cancer, 1/20/2015
  • The Role of Registries and Tumor Banking in Rare Pediatric Tumors  
    Farzana Pashankar, Gianni Bisogno, Raul Ribeiro, Yoav Messinger, KrisAnn Schultz, Carlos Rodriguez-Galindo, Curr Pediatr Rep, 1/1/2015
  • Pediatric and Adolescent Extracranial Germ Cell Tumors – The Road to Collaboration  
    Thomas A. Olson, Matthew J. Murray, Carlos Rodriguez-Galindo,James C. Nicholson, Deborah F. Billmire, Mark D. Krailo, Ha Dang, James F. Amatruda, Claire M.Thornton, G...., J Clin Oncol, 1/1/2015

Books/Book Chapters

Abstracts/Posters

  • Orbital masses, two cases reports.
    Pashankar F, American Society of Pediatric Hematology Oncology Annual Meeting, 1/1/2014
  • Development of a Multi-Disciplinary Inpatient Program for Children with Sickle Cell Disease Admitted for Vaso-Occulusive Crisis.
    Pashankar F, 6th Annual Sickle Cell Disease Research and Education Symposium, Hollywood, FL, 1/1/2013
  • Longitudnal FU of elevated TR jet Velocity in Children with Sickle Cell Disease
    Pashankar F, American Society of Pediatric Hematology Oncology Annual Meeting, Miami, FL, 1/1/2013

Lectures

  • Reduction in Hospital Days Using a Multidisciplinary Approach for Pediatric Patients with Sickle Cell Disease 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Heredity and Sickle Cell Disease 
    Bethany Community School - 1/1/2015
  • Using Every Child Protocol as a Rare Tumor Registry 
    1/1/2014

Other

  • Management of Pain in Children with Sickle Cell Disease. 
    Pashankar F, Yale New Haven Hospital

Press Mentions

  • NCI Grants $1.8M for Cancer Genome Atlas Research, Sarah Cannon Names Navneet Majhail Physician-in-Chief of Blood Cancers, and More
    NCI Grants $1.8M for Cancer Genome Atlas Research, Sarah Cannon Names Navneet Majhail Physician-in-Chief of Blood Cancers, and MoreOctober 1st, 2021
  • Yale Names Head of Pediatric Oncology
    Yale Names Head of Pediatric OncologyJune 29th, 2021
  • New Strategies for Treating Pediatric Sickle Cell Disease
    New Strategies for Treating Pediatric Sickle Cell DiseaseFebruary 4th, 2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: